Common Contracts
5 similar Employment Agreement contracts by Aprea Therapeutics, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Eyal C. Attar, M.D. (the “Executive”), is made and entered into as of September 26, 2019, and will become effective, if at all, upon the date of closing of the Company’s initial public offering of stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and John P. Hamill (the “Executive”), is made and entered into as of January 30, 2023 and shall become effective January 30, 2023 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Oren Gilad (the “Executive”), is made and entered into as of May 16, 2022 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Scott M. Coiante (the “Executive”), is made and entered into as of September 26, 2019, and will become effective, if at all, upon the date of closing of the Company’s initial public offering of stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Christian S. Schade (the “Executive”), is made and entered into as of September 26, 2019, and will become effective, if at all, upon the date of closing of the Company’s initial public offering of stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
